Home » MORPHOSYS 3% HIGHER PRE-MKT ON R&D DEAL
MORPHOSYS 3% HIGHER PRE-MKT ON R&D DEAL
May 17, 2006
MorphoSys +3% pre-market on the back of the company's R&D agreement with Schering-Plough (SGP), traders say. Under the terms of the two-year deal, MorphoSys will receive an upfront payment, annual user fees and optional R&D funding.
KEYWORDS Daily International Pharma Alert